Subtopic Deep Dive

Dementia Prevalence and Epidemiology
Research Guide

What is Dementia Prevalence and Epidemiology?

Dementia prevalence and epidemiology studies global incidence, prevalence rates, and risk factors of dementia through population-based research and meta-analyses across aging populations.

This subtopic analyzes trends in dementia occurrence using protocols like those from the 10/66 Dementia Research Group (Prince et al., 2007, 354 citations). Key works include national reports such as the China Alzheimer Report 2022 (Ren et al., 2022, 321 citations) and regional analyses like Dementia in Latin America (Parra et al., 2018, 195 citations). Over 10 provided papers span 2001-2022 with cumulative citations exceeding 5,000.

Curated Papers

Key Challenges

Why It Matters

Epidemiological data from van der Flier (2005, 543 citations) guides risk factor identification like benzodiazepine use (Billioti de Gage et al., 2012, 422 citations), informing public health policies. Prevalence studies such as Okura et al. (2010, 207 citations) on neuropsychiatric symptoms link to functional limitations, aiding resource allocation in aging societies. Reports like Ren et al. (2022) highlight rising burdens in China, shaping healthcare planning for projected dementia increases.

Key Research Challenges

Population Variability in Prevalence

Dementia rates differ across regions due to genetic, lifestyle, and diagnostic variations, complicating global comparisons (Parra et al., 2018). Studies like the 10/66 protocols address low-middle income settings but face standardization issues (Prince et al., 2007). Meta-analyses require harmonized methods for accurate trends.

Risk Factor Causality Attribution

Associating factors like benzodiazepines with dementia risk demands longitudinal designs to rule out reverse causation (Billioti de Gage et al., 2012). Prospective cohorts reveal increased risks but need pooled analyses for robustness. Confounding by indication persists in observational data.

MCI to Dementia Progression Rates

Conversion from mild cognitive impairment to dementia shows non-linear patterns, challenging predictive models (Busse et al., 2006, 173 citations). Petersen et al. (2001, 2066 citations) recommend monitoring but lifetime rates vary widely. Accurate forecasting requires time-dependent analyses.

Essential Papers

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]

Ronald C. Petersen, J E Stevens, Mary Ganguli et al. · 2001 · Neurology · 2.1K citations

There were sufficient data to recommend the evaluation and clinical monitoring of persons with mild cognitive impairment due to their increased risk for developing dementia (Guideline). Screening i...

Epidemiology and risk factors of dementia

Wiesje M. van der Flier · 2005 · Journal of Neurology Neurosurgery & Psychiatry · 543 citations

ementia refers to a syndrome that is characterised by progressive deterioration of cognitive functions.Neuropsychiatric symptoms, such as apathy, agitation, and depression, are also common.With inc...

Benzodiazepine use and risk of dementia: prospective population based study

Sophie Billioti de Gage, Bernard Bégaud, Fabienne Bazin et al. · 2012 · BMJ · 422 citations

In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzod...

The protocols for the 10/66 dementia research group population-based research programme

Martin Prince, Cleusa P. Ferri, Daisy Acosta et al. · 2007 · BMC Public Health · 354 citations

The China Alzheimer Report 2022

Ru‐Jing Ren, Jinlei Qi, Shaohui Lin et al. · 2022 · General Psychiatry · 321 citations

China’s population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer’s disease (AD) and related deme...

Clinical features and multidisciplinary approaches to dementia care

Stuart MacDonald, Grand, Caspar · 2011 · Journal of Multidisciplinary Healthcare · 255 citations

Dementia is a clinical syndrome of widespread progressive deterioration of cognitive abilities and normal daily functioning. These cognitive and behavioral impairments pose considerable challenges ...

Prevalence of Neuropsychiatric Symptoms and Their Association with Functional Limitations in Older Adults in the United States: The Aging, Demographics, and Memory Study

Toru Okura, Brenda L. Plassman, David C. Steffens et al. · 2010 · Journal of the American Geriatrics Society · 207 citations

OBJECTIVES: To estimate the prevalence of neuropsychiatric symptoms and examine their association with functional limitations. DESIGN: Cross‐sectional analysis. SETTING: The Aging, Demographics, an...

Reading Guide

Foundational Papers

Start with Petersen et al. (2001, 2066 citations) for MCI-dementia links and screening; van der Flier (2005, 543 citations) for core epidemiology and risks; Prince et al. (2007, 354 citations) for global protocols.

Recent Advances

Ren et al. (2022, 321 citations) for China trends; Parra et al. (2018, 195 citations) for Latin America; Okura et al. (2010, 207 citations) for neuropsychiatric prevalence.

Core Methods

Population-based cohorts (10/66 protocols), prospective studies (benzodiazepine risks), cross-sectional analyses (ADAMS study), Mini-Mental State Examination screening.

How PapersFlow Helps You Research Dementia Prevalence and Epidemiology

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to query 'dementia prevalence Latin America,' retrieving Parra et al. (2018) as a core regional study, then citationGraph reveals connections to Prince et al. (2007) 10/66 protocols, and findSimilarPapers uncovers related global epidemiology papers.

Analyze & Verify

Analysis Agent employs readPaperContent on Ren et al. (2022) to extract China-specific prevalence stats, verifies claims via verifyResponse (CoVe) against Petersen et al. (2001) guidelines, and runs PythonAnalysis with pandas to compute meta-prevalence rates across studies, graded by GRADE for evidence strength in risk factor analyses.

Synthesize & Write

Synthesis Agent detects gaps in benzodiazepine-dementia links post-Billioti de Gage et al. (2012), flags contradictions with van der Flier (2005), while Writing Agent uses latexEditText, latexSyncCitations for Ren et al. (2022), and latexCompile to produce formatted reviews; exportMermaid visualizes prevalence trend diagrams.

Use Cases

"Analyze prevalence trends from 10/66 studies using Python."

Research Agent → searchPapers('10/66 dementia') → Analysis Agent → readPaperContent(Prince 2007) → runPythonAnalysis(pandas meta-analysis of rates) → CSV export of incidence tables.

"Write LaTeX review on China dementia epidemiology."

Research Agent → exaSearch('China Alzheimer Report') → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Ren 2022) → latexCompile → PDF output.

"Find code for dementia risk modeling from papers."

Research Agent → citationGraph(van der Flier 2005) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python sandbox verification of models.

Automated Workflows

Deep Research workflow conducts systematic reviews by chaining searchPapers on 'dementia prevalence global' to analyze 50+ papers like Petersen (2001) and Parra (2018), outputting structured reports with GRADE scores. DeepScan applies 7-step verification to risk factor claims from Billioti de Gage (2012), including CoVe checkpoints. Theorizer generates hypotheses on progression rates from Busse (2006) data.

Try Doxa for Dementia Prevalence and Epidemiology Research

Frequently Asked Questions

What defines dementia prevalence and epidemiology?

It examines global incidence, prevalence, and risk factors via population studies like 10/66 protocols (Prince et al., 2007).

What methods are used in this subtopic?

Prospective cohorts, meta-analyses, and standardized assessments like Mini-Mental State Examination from Petersen et al. (2001).

What are key papers?

Petersen et al. (2001, 2066 citations) on MCI detection; van der Flier (2005, 543 citations) on epidemiology; Ren et al. (2022, 321 citations) on China.

What open problems exist?

Non-linear MCI progression (Busse et al., 2006), regional disparities (Parra et al., 2018), and causality in risks like benzodiazepines (Billioti de Gage et al., 2012).